Clinical trials

  • estriol for Breast cancer | Vulvovaginal atrophy
  • NAZARTINIB for Advanced cancer
  • Darolutamide for Prostate cancer (hormone‑naïve)
  • SEMAGLUTIDE for Craniopharyngioma
  • MAT2A inhibitor for Advanced solid tumors
  • RO7568282 for Parkinson's disease
  • LECANEMAB (BAN2401) for Preclinical Alzheimer’s disease|Early preclinical Alzheimer’s disease
  • [AL[18F]F]FAPI-74 for Prostate cancer
  • Botulinum toxin type A for Post-stroke spasticity
  • CLOSTRIDIUM BOTULINUM, NEUROTOXIN SEROTYPE A/B for Episodic migraine | Chronic migraine
  • NNC0519-0130 for Chronic kidney disease | Type 2 diabetes mellitus | Obesity
  • AZD5492 for B-cell malignancies|Diffuse large B-cell lymphoma|Follicular lymphoma|Mantle cell lymphoma|Chronic lymphocytic leukemia|Small lymphocytic lymphoma|Relapsed or refractory B-cell malignancies